Humoral Immunity: From Regulation to Dysregulation
体液免疫:从调节到失调
基本信息
- 批准号:10469165
- 负责人:
- 金额:$ 0.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-21 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAllergicAllergic DiseaseAntibodiesAntibody ResponseAntigensAreaAutoantigensAutoimmune DiseasesAutoimmunityAutomobile DrivingB-LymphocytesCellsChronicCollaborationsCommunitiesComplexDevelopmentDiagnosticEducational workshopFeedbackFosteringFutureGenerationsGenetic ScreeningGenomicsGermanyGoalsHeartHumoral ImmunitiesImmuneImmune System DiseasesImmune responseInfectionInflammatoryInvestigationKnowledgeLeadLearningLigandsMemory B-LymphocyteMentorsMethodologyMethodsOutcomeParticipantPathologicPathologyPathway interactionsPlayProcessReactionRegulationResearchResearch PersonnelScientistStructure of germinal center of lymph nodeT-LymphocyteTimeTissuesVaccine DesignVaccinesWorkacute infectionadaptive immune responsecareercareer developmentchronic infectionclinical practicecommensal microbesdesignimaging geneticsinnovationinterestknowledge basenovelpathogenplasma cell differentiationpostersreceptorresponsesecondary lymphoid organsymposiumtoolvaccine response
项目摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Humoral Immunity: From Regulation to
Dysregulation, organized by Drs. Victor L.J. Tybulewicz, Kai-Michael Toellner, Julie Zikherman and Pamela
Schwartzberg. The conference will be held in Hannover, Germany from April 3-6, 2022.
Humoral immunity is at the heart of the adaptive immune response. The germinal center reaction orchestrates
critical B cell-T cell collaboration, leading to the generation of B cell memory and long-lived affinity-matured
protective antibodies. This key immune response has been extensively studied, and, as a result, there has
been an increasingly refined understanding of the ligands, receptors, and intra-cellular pathways that are
involved in this process. However, many aspects of this remarkable process, as it plays out in infections,
vaccine responses, and chronic immunological diseases, remain unknown. For instance, there is no clear
understanding on how B cells integrate complex antigenic and co-stimulatory inputs over time to make critical
cell fate decisions, including the process of clonal selection in the germinal center as well as memory B cell
and long-lived plasma cell differentiation. Additionally, there is not a full appreciation for the spectrum of ‘non-
canonical’ B cell responses to various chronic and acute infections, especially those occurring in tissues rather
than secondary lymphoid organs. And finally, many unanswered questions remain about normal and abnormal
B cell responses to commensal flora, allergic antigens, and self-antigens that are essential to address if
researchers hope to understand dysregulated B cell immune responses in inflammatory, allergic, and
autoimmune diseases. Therefore, this conference brings together scientists focused on both the B cell and the
Tfh cell contributions to humoral immunity in order to share innovative research focused on addressing this
broad set of questions. It is a goal of this conference to identify areas of future investigation, foster
collaboration, and collectively generate the knowledge base required to design better vaccines and more
precise strategies to treat diseases of immune dysregulation.
抽象的
请求支持Keystone研讨会会议,标题为“体液免疫:从监管到
失调,由Drs组织。 Victor L.J. Tybulewicz,Kai-Michael Toellner,Julie Zikherman和Pamela
Schwartzberg。会议将于2022年4月3日至6日在德国汉诺威举行。
体液免疫学是适应性免疫响应的核心。生发中心反应协调
临界B细胞-T细胞协作,导致B细胞记忆的产生和长寿的亲和力成熟
保护性抗体。这种关键的免疫反应已广泛研究,因此,
是对配体,接收器和细胞内途径的越来越精致的理解
参与此过程。但是,这种非凡过程的许多方面,因为它在感染中发挥了作用,
疫苗反应和慢性免疫疾病仍然未知。例如,没有清楚的
了解B细胞如何随着时间的推移整合复杂的抗原和共同刺激输入
细胞脂肪决策,包括生发中心的克隆选择过程以及记忆B细胞
和长寿命的浆细胞分化。此外,对非 - 非 -
规范的B细胞对各种慢性和急性感染的反应,尤其是在组织中发生的人
比继发性淋巴器官。最后,关于正常和异常的许多未解决的问题仍然存在
B细胞对共生菌群,过敏抗原和自我抗原的反应,对于解决
研究人员希望了解炎症,过敏和
自身免疫性疾病。因此,这次会议汇集了科学家,专注于B细胞和
TFH细胞对体液免疫学的贡献,以分享专注于解决此问题的创新研究
广泛的问题。该会议的目标是确定未来调查的领域,福斯特
协作,并集体生成设计更好的疫苗所需的知识库
治疗免疫失调疾病的精确策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thale Cross Jarvis其他文献
Thale Cross Jarvis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thale Cross Jarvis', 18)}}的其他基金
Autophagy and Neurodegeneration: Mechanisms to Therapies
自噬和神经退行性变:治疗机制
- 批准号:
10608666 - 财政年份:2023
- 资助金额:
$ 0.4万 - 项目类别:
Malaria: Confronting Challenges From Drug Discovery to Treatment
疟疾:面临从药物发现到治疗的挑战
- 批准号:
10468493 - 财政年份:2022
- 资助金额:
$ 0.4万 - 项目类别:
Modern Phenotypic Drug Discovery: From Chemical Biology to Therapeutics
现代表型药物发现:从化学生物学到治疗学
- 批准号:
10468419 - 财政年份:2022
- 资助金额:
$ 0.4万 - 项目类别:
相似国自然基金
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE
开发高度敏感和特异的 POCT 测试哮喘触发过敏性 IgE
- 批准号:
10600767 - 财政年份:2023
- 资助金额:
$ 0.4万 - 项目类别:
Mechanisms of enhanced food allergy by S. aureus skin colonization in Atopic Dermatitis
特应性皮炎中金黄色葡萄球菌皮肤定植增强食物过敏的机制
- 批准号:
10638821 - 财政年份:2023
- 资助金额:
$ 0.4万 - 项目类别:
Critical role for Solute Carrier Proteins (SLCs) for mast cell function
溶质载体蛋白 (SLC) 对肥大细胞功能的关键作用
- 批准号:
10537469 - 财政年份:2022
- 资助金额:
$ 0.4万 - 项目类别:
Critical role for Solute Carrier Proteins (SLCs) for mast cell function
溶质载体蛋白 (SLC) 对肥大细胞功能的关键作用
- 批准号:
10652657 - 财政年份:2022
- 资助金额:
$ 0.4万 - 项目类别:
Characterizing the IgG1 Memory B cells that are precursors of pathogenic IgE
表征作为致病性 IgE 前体的 IgG1 记忆 B 细胞
- 批准号:
10725159 - 财政年份:2022
- 资助金额:
$ 0.4万 - 项目类别: